| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |